Zymeworks Inc.

ZYME

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001937653

SEC filings (opens in a new tab)

No open-market purchases or sales by Zymeworks Inc. insiders were filed in the last 90 days; 202 institutions reported holding it in 13F filings for Q2 2026, worth $1.79B in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Zymeworks Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of ZYME: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Of which not filed for Q3 2021	Q3 2021	Change
Holders	109	1	123	+15
Shares	34.5M	1.06M	36.8M	+3.38M (+10.1%)
Value	$1.20B	$36.8M	$1.07B	−$93.7M (−8.1%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Zymeworks Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to ZYME in Q3 2021
Institution	Shares	Value	% of portfolio
Pictet Asset Management SA	1,767,508	$51.3M	0.06%
Camber Capital Management LP	750,000	$21.8M	0.81%
Wellington Management Group LLP	599,135	$17.4M	0.00%
Sofinnova Investments, Inc.	410,619	$11.9M	0.76%
Maso Capital Partners Ltd	94,720	$2.75M	1.24%
Gsa Capital Partners LLP	50,001	$1.45M	0.15%
Integral Health Asset Management, LLC	50,000	$1.45M	0.42%
ExodusPoint Capital Management, LP	44,125	$1.28M	0.02%
Marshall Wace North America L.P.	40,619	$1.18M	0.01%
Kennedy Capital Management, Inc.	36,467	$1.06M	0.02%
Jump Financial, LLC	33,841	$983.0K	0.07%
Gyon Technologies Capital Management, LP	33,737	$980.0K	0.26%
California State Teachers Retirement System	30,323	$881.0K	0.00%
K.J. Harrison & Partners Inc	30,000	$876.0K	0.13%
Parkman Healthcare Partners LLC	30,000	$871.0K	0.22%
Truist Financial Corp	26,000	$755.0K	0.00%
Two Sigma Investments, LP	18,532	$538.0K	0.00%
Silphium Asset Management Ltd	15,000	$435.6K	0.18%
ACT Capital Management, LLC	14,000	$407.0K	0.21%
Algert Global LLC	12,200	$354.0K	0.05%
Vigilare Wealth Management	10,200	$296.0K	0.18%
Dynamic Technology Lab Private Ltd	9,490	$276.0K	0.03%
Caption Management, LLC	8,200	$238.0K	0.02%
1623 Capital LLC	7,724	$224.0K	0.09%
Values First Advisors, Inc.	7,072	$205.0K	0.13%
SG3 Management, LLC	6,100	$177.0K	0.06%
Knott David M	4,000	$116.0K	0.05%
Compagnie Lombard Odier SCmA	3,000	$87.0K	0.00%
Northwestern Mutual Wealth Management Co	200	$6.00K	0.00%
Consolidated Planning Corp	61	$2.00K	0.00%

Sold out (15)

Institutions that held Zymeworks Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of ZYME in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Holocene Advisors, LP	923,578	$32.0M
Candriam Luxembourg S.C.A.	473,124	$16.4M
Point72 Asset Management, L.P.	78,300	$2.72M
Nuveen Asset Management, LLC	70,351	$2.44M
Victory Capital Management Inc	36,810	$1.28M
Squarepoint Ops LLC	28,975	$1.00M
HighVista Strategies LLC	25,452	$883.0K
Dimensional Fund Advisors LP	17,260	$599.0K
Qube Research & Technologies Ltd	11,080	$384.0K
DekaBank Deutsche Girozentrale	6,700	$233.0K
Indie Asset Partners, LLC	6,450	$224.0K
Group One Trading, L.P.	6,245	$217.0K
Boothbay Fund Management, LLC	5,961	$207.0K
Exane Derivatives	632	$21.9K
Massmutual Trust Co FSB	23	$1.00K

Not filed for Q3 2021 yet (1)

Institutions that held Zymeworks Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ZYME in Q2 2021 that haven't filed for Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Pictet Asset Management Ltd	1,060,355	$36.8M